Revyve has raised nearly €24 million in Series B financing to accelerate the roll-out of its functional yeast proteins, designed to replace eggs and additives in mainstream food categories.

Revyve has opened a facility in the Netherlands, supporting production of its new gluten-free ingredient line made from baker's yeast.